Healthcare provider profile · identity verified

Frederick Hudson Dore, MD

Internal Medicine · BREMERTON, WA · NPI 1851372395

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	159
Losartan Potassium	Losartan Potassium	385	112
Amlodipine Besylate	Amlodipine Besylate	302	86
Levothyroxine Sodium	Levothyroxine Sodium	287	85
Lisinopril	Lisinopril	283	80
Gabapentin	Gabapentin	245	72
Hydrochlorothiazide	Hydrochlorothiazide	184	45
Metoprolol Succinate	Metoprolol Succinate	182	56
Tamsulosin Hcl	Tamsulosin Hcl	176	56
Metformin Hcl	Metformin Hcl	148	50
Rosuvastatin Calcium	Rosuvastatin Calcium	125	42
Omeprazole	Omeprazole	121	43
Citalopram Hbr	Citalopram Hydrobromide	111	30
Simvastatin	Simvastatin	108	34
Tramadol Hcl	Tramadol Hcl	108	37
Xarelto	Rivaroxaban	102	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	101	32
Prednisone	Prednisone	101	39
Allopurinol	Allopurinol	100	29
Montelukast Sodium	Montelukast Sodium	94	26
Furosemide	Furosemide	93	33
Ezetimibe	Ezetimibe	87	27
Jardiance	Empagliflozin	85	18
Escitalopram Oxalate	Escitalopram Oxalate	80	11
Spironolactone	Spironolactone	79	24
Albuterol Sulfate Hfa	Albuterol Sulfate	77	35
Mirtazapine	Mirtazapine	77	20
Alendronate Sodium	Alendronate Sodium	75	23
Eliquis	Apixaban	75	17
Finasteride	Finasteride	74	22
Alprazolam	Alprazolam	71	23
Carvedilol	Carvedilol	66	21
Pantoprazole Sodium	Pantoprazole Sodium	64	18
Metformin Hcl Er	Metformin Hcl	63	21
Trazodone Hcl	Trazodone Hcl	63	21
Buspirone Hcl	Buspirone Hcl	55	14
Sertraline Hcl	Sertraline Hcl	54	15
Pravastatin Sodium	Pravastatin Sodium	53	17
Donepezil Hcl	Donepezil Hcl	51	12
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Potassium Chloride	Potassium Chloride	42	13
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Celecoxib	Celecoxib	39	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	39	suppressed
Atenolol	Atenolol	38	12
Duloxetine Hcl	Duloxetine Hcl	38	12
Estradiol	Estradiol	36	suppressed
Meloxicam	Meloxicam	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	11
Glimepiride	Glimepiride	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	19
Ozempic	Semaglutide	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Famotidine	Famotidine	29	suppressed
Cephalexin	Cephalexin	26	16
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Azithromycin	Azithromycin	23	22
Glipizide	Glipizide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Morphine Sulfate	Morphine Sulfate	22	suppressed
Testosterone	Testosterone	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Fluconazole	Fluconazole	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Levetiracetam	Levetiracetam	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Primidone	Primidone	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Glyburide	Glyburide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Forteo	Teriparatide	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Colchicine	Colchicine	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error